Kenji Namoto
Novartis (China)(CN)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Peptidase Inhibition and Analysis, Diabetes Treatment and Management, Chemical Synthesis and Analysis, Neuropeptides and Animal Physiology
Most-Cited Works
- → Chemical Synthesis and Biological Evaluation of cis- and trans-12,13-Cyclopropyl and 12,13-Cyclobutyl Epothilones and Related Pyridine Side Chain Analogues(2001)190 cited
- → Recent developments in the chemistry, biology and medicine of the epothilones(2001)124 cited
- → Interaction of Epothilone Analogs with the Paclitaxel Binding Site(2004)117 cited
- → Synthesis of N-heterocycles via lactam-derived ketene aminal phosphates. Asymmetric synthesis of cyclic amino acids.(1998)99 cited
- → Interaction of α-and β-Oligoarginine-Acids and Amides with Anionic Lipid Vesicles: A Mechanistic and Thermodynamic Study(2006)74 cited
- → Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes(2011)71 cited
- → Chemical and Biological Investigations of β‐Oligoarginines(2004)70 cited
- → Chemical synthesis and biological evaluation of novel epothilone B and trans-12,13-cyclopropyl epothilone B analogues(2002)53 cited
- → In-cell Selectivity Profiling of Serine Protease Inhibitors by Activity-based Proteomics(2008)43 cited
- → Interaction of Epothilone Analogs with the Paclitaxel Binding SiteRelationship between Binding Affinity, Microtubule Stabilization, and Cytotoxicity(2004)42 cited